Using a cohort comprising 2,780 patients with breast cancer, Foekens et al. have demonstrated that the levels of uPA and PAI-1 can be used as independent prognostic markers for poor relapse-free survival as well as of overall survival (145). Here, SERPINE1 is linked to breast carcinoma.